Benign Prostatic Hyperplasia Devices: Global Strategic Business Report

Report
192 Pages
December 2023
Region: Global
Global Industry Analysts, Inc
ID: 5139478

Quick Summary:

In an ever-evolving healthcare landscape, staying informed about significant markets is key to impactful decision-making. Our detailed report on the global market for Benign Prostatic Hyperplasia Devices provides an invaluable resource for those seeking to understand this rapidly growing industry.

Estimated at US$499.1 million in 2022 and projected to reach US$734.6 million by 2030, this market is on a remarkable growth course. With a comprehensive analysis of critical segments like TURP and Laser Therapy, the report sheds light on potential investment opportunities. Get in-depth insights into noteworthy geographic markets like the US, China, Japan, Canada and Germany, each exhibiting promising CAGR over the next decade.

Get an edge over the competition with our special coverage on vital market players like Boston Scientific Corporation, Karl Storz GmbH & Co., Lumenis Ltd., Olympus Corporation, and more. Significantly, each purchase comes with complimentary updates for a year, ensuring you stay ahead of the curve with the latest industry trends and developments.

Global Benign Prostatic Hyperplasia Devices Market to Reach $734.6 Million by 2030

The global market for Benign Prostatic Hyperplasia Devices estimated at US$499.1 Million in the year 2022, is projected to reach a revised size of US$734.6 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. TURP, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$353.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Laser Therapy segment is readjusted to a revised 5.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $149.6 Million, While China is Forecast to Grow at 4.7% CAGR

The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$149.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$129.5 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 38 Featured) -

Boston Scientific Corporation
Karl Storz GmbH & Co. KG
Lumenis Ltd.
Olympus Corporation
Teleflex Inc.
Urologix, Inc.

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

Frequently Asked Questions about the Global Market for Benign Prostatic Hyperplasia Devices

What is the estimated value of the Global Market for Benign Prostatic Hyperplasia Devices?

The Global Market for Benign Prostatic Hyperplasia Devices was estimated to be valued at $499.1 Million in 2022.

What is the growth rate of the Global Market for Benign Prostatic Hyperplasia Devices?

The growth rate of the Global Market for Benign Prostatic Hyperplasia Devices is 5.0%, with an estimated value of $734.6 Million by 2030.

What is the forecasted size of the Global Market for Benign Prostatic Hyperplasia Devices?

The Global Market for Benign Prostatic Hyperplasia Devices is estimated to be worth $734.6 Million by 2030.

Who are the key companies in the Global Market for Benign Prostatic Hyperplasia Devices?

Key companies in the Global Market for Benign Prostatic Hyperplasia Devices include Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Lumenis Ltd., Olympus Corporation, Teleflex Inc. and Urologix, Inc..

Report Attribute	Details
No. of Pages	192
Published	December 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 499.1 Million
Forecasted Market Value ( USD ) by 2030	$ 734.6 Million
Compound Annual Growth Rate	5.0%
Regions Covered	Global

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Benign Prostatic Hyperplasia Devices - Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for TURP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Laser Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 18: World 16-Year Perspective for Urology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 19: World Benign Prostatic Hyperplasia Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 23: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 24: USA Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 25: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 26: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 27: USA Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 28: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

CANADA

Table 29: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 30: Canada Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 31: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 32: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 33: Canada Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 34: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

JAPAN

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 35: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 36: Japan Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 37: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 38: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 39: Japan Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 40: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

CHINA

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 41: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 42: China Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 43: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 44: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 45: China Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 46: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

EUROPE

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 47: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 48: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 49: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 50: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 51: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 52: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 53: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 54: Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 55: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

FRANCE

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 56: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 57: France Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 58: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 59: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 60: France Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 61: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

GERMANY

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 62: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 63: Germany Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 64: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 65: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 66: Germany Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 67: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

ITALY

Table 68: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 69: Italy Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 70: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 71: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 72: Italy Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 73: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

UNITED KINGDOM

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 74: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 75: UK Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 76: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 77: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 78: UK Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 79: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 80: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 81: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 82: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 83: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 84: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 85: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 87: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 88: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 90: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 91: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

REST OF WORLD

Table 92: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 93: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 94: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2023 & 2030
Table 95: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 96: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 97: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

Boston Scientific Corporation
Karl Storz GmbH & Co. KG
Lumenis Ltd.
Olympus Corporation
Teleflex Inc.
Urologix, Inc.

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4725EUR$4,950USD£4,054GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€8977EUR$9,405USD£7,702GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14174EUR$14,850USD£12,162GBP

Quick Summary:

Global Benign Prostatic Hyperplasia Devices Market to Reach $734.6 Million by 2030

The U.S. Market is Estimated at $149.6 Million, While China is Forecast to Grow at 4.7% CAGR

Select Competitors (Total 38 Featured) -

What's New?

What is the estimated value of the Global Market for Benign Prostatic Hyperplasia Devices?

What is the growth rate of the Global Market for Benign Prostatic Hyperplasia Devices?

What is the forecasted size of the Global Market for Benign Prostatic Hyperplasia Devices?

Who are the key companies in the Global Market for Benign Prostatic Hyperplasia Devices?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

The Global Market for Medical Devices, 13th Edition

Benign Prostatic Hyperplasia Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application

Benign Prostatic Hyperplasia Device Market Analysis, 2023 - Industry Trends, Market Size, Growth Opportunities, Market Share, Forecast by Types, Applications, Countries, and Companies, 2018 to 2030

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

Nephrology And Urology Devices: Global Strategic Business Report